Increased Frequency of Severe Hypoglycemia with the Modified-Release Gliclazide Compared to Glimepiride in Diabetic Older Adults; Propensity Score-Adjusted Analysis.
Ahmed Fouad AlgendyBen IlligensAmeena AlyazeediPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)
Using gliclazide MR for older patients may not be a relatively safer alternative to avoid severe hypoglycemia and its possible consequences compared to glimepiride. It may be added to glimepiride in the Beers list of medications to be avoided in older adults.